Insider transaction filing: AVGO — Broadcom Inc.
Why now
Thesis: Routine Form 4 for Broadcom; no buy/sell detail.
Catalyst to watch: Transaction details if disclosed.
Main risk: No directional signal inferable.
Why it matters
Routine Form 4 for Broadcom; without buy/sell detail it carries no directional information.
Details
Broadcom Inc. filed SEC Form 4 on 2026-09-17.